Recent Quotes (30 days)

You have no recent quotes
chg | %

Biosign Technologies Inc  

(Public, CVE:BIO)   Watch this stock  
0.0100
-0.0050 (-33.33%)
Oct 30 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.01 - 0.01
52 week 0.01 - 0.06
Open 0.01
Vol / Avg. 16,000.00/77,815.00
Mkt cap 2.78M
P/E     -
Div/yield     -
EPS -0.04
Shares 278.23M
Beta 0.14
Inst. own     -

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin -5296.53% -8967.79%
Operating margin -5296.53% -8967.79%
EBITD margin - -5321.02%
Return on average assets -190.30% -116.38%
Return on average equity -2110.45% -279.32%
Employees 2 -
CDP Score - -

Address

Unit 13, 3715 Laird Drive
MISSISSAUGA, ON L5L 0A3
Canada
+1-416-2189800 (Phone)
+1-647-3618255 (Fax)

Website links

Description

Biosign Technologies Inc. is a manufacturer and vendor of medical devices, healthcare information systems and related services. It delivers cloud-based systems for non-invasive monitoring of common health risks associated with blood pressure, life style, medication and chronic disease management. The Company provides automated, software enabled health information solutions, including the Pulsewave Health Monitor and the Healthanywhere Patient monitoring / self-care platform. The Company's Pulsewave Health Monitor solution enables Pulse data collection for cardiovascular clinical decision support and self-care, while its Healthanywhere solution offers remote patient monitoring and patient centered care management. In August 2014, it announced the completion of share purchase agreement with 3282909 Nova Scotia Ltd, under which it has sold 12.5% of its 51% ownership interest of MECK Medical GmbH. In September 2014, it completes sale of hardware division to Cloud DX Inc.